RML Hospital's clinical study reports that Tofacitinib shows a remarkable 90% improvement in chronic hand eczema symptoms for 12 of 15 patients within four weeks. The condition primarily affects ...

NEW DELHI: In a significant breakthrough for those suffering from chronic hand eczema, a widespread skin condition resistant to existing treatments, a clinical study by RML Hospital has shown a ...

People with chronic hand eczema (CHE) have reported the serious impact the condition can have on their daily lives in a UK survey. The poll – commissioned by LEO Pharma and supported by Allergy ...

Hand eczema, also called hand dermatitis, is an inflammatory skin condition that causes dry, itchy rashes on the hands. The skin may blister and crack, and the condition can be painful.

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Previous studies suggest that patients older than 60 who develop chronic, unexplained eczema are taking more drugs than patients of the same age without eczema and that elderly patients with ...

It was the top story in allergy/asthma last week. In another top story, survey results revealed that chronic hand eczema had a significant negative impact on daily living activities and quality of ...

However, it often occurs as a chronic condition that involves ... It can be challenging to live with dyshidrotic eczema because it affects the hands and feet. Some people with the condition ...

Background: Chronic vesicular hand dermatitis is a chronic disease ... in a 41-year-old woman with a 3-year history of dyshidrotic eczema.

• Topical treatments: Over-the-counter 1% hydrocortisone cream can help with mild flare-ups. For more severe cases, pediatricians may prescribe stronger topical steroids or calcineurin inhibitors.